Legend Biotech Corp (LEGN) — Financial Flexibility Index
Legend Biotech Corp (LEGN) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $-280.55K (operating CF $-20.90 Million minus capex $20.62 Million) represents 0% of total liabilities ($521.32 Million). Check Legend Biotech Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Legend Biotech Corp Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Legend Biotech Corp across 9 annual periods. For the full cash flow conversion analysis, see LEGN cash flow conversion.
Annual Financial Flexibility Index for Legend Biotech Corp (2017–2025)
Year-by-year free cash flow to debt coverage for Legend Biotech Corp. Explore Legend Biotech Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.04x | $-32.89 Million | $-100.47 Million | $731.60 Million | ▲ +78.2% |
| 2024 | -0.21x | $-129.93 Million | $-144.03 Million | $629.61 Million | ▲ +66.7% |
| 2023 | -0.62x | $-370.55 Million | $-393.28 Million | $597.24 Million | ▼ -103.3% |
| 2022 | -0.31x | $-179.01 Million | $-201.28 Million | $586.65 Million | ▲ +29.5% |
| 2021 | -0.43x | $-153.06 Million | $-198.47 Million | $353.52 Million | ▲ +72.5% |
| 2020 | -1.58x | $-192.72 Million | $-223.00 Million | $122.27 Million | ▼ -1374.3% |
| 2019 | -0.11x | $-43.90 Million | $-83.06 Million | $410.58 Million | ▼ -113.7% |
| 2018 | 0.78x | $328.70 Million | $307.68 Million | $420.40 Million | ▲ +11995.0% |
| 2017 | -0.01x | $-1.49 Million | $-2.38 Million | $226.53 Million | — |